C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease

Cited by (1,014)

Items 301–400 of 1,014

  1. State of the Art Reviews: The Anti-Inflammatory Actions of Exercise Training
    Flynn, Michael G., McFarlin, Brian K., Markofski, Melissa M. · 2007 · American Journal of Lifestyle Medicine
  2. The Role of High-Density Lipoprotein in Inflammation
    Mohamad Navab, G.M. Anantharamaiah, Alan M. Fogelman · 2005 · Trends in Cardiovascular Medicine
  3. C-Reactive Protein Reassessed
    Alan R. Tall · 2004 · New England Journal of Medicine
  4. Long‐chain n‐3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease
    de Roos, Baukje, Mavrommatis, Yiannis, Brouwer, Ingeborg A · 2009 · British Journal of Pharmacology
  5. The use of high-sensitivity assays for C-reactive protein in clinical practice
    Kiran Musunuru, Brian G. Kral, Roger Scott Blumenthal, Valentı́n Fuster, Catherine Y. Campbell, Ty J. Gluckman, Richard A. Lange, Eric J. Topol, James T. Willerson, Milind Y. Desai et al. · 2008 · Nature Clinical Practice Cardiovascular Medicine
  6. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease
    William L. Roberts · 2004 · Circulation
  7. Leisure time physical activity, risk of depressive symptoms, and inflammatory mediators: The English Longitudinal Study of Ageing
    Mark Hamer, Gerard J. Molloy, Cesar Messias de Oliveira, Panayotes Demakakos · 2009 · Psychoneuroendocrinology
  8. Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndromes: a meta-analysis of longitudinal studies
    Liu He, Xin-yi Tang, Wenhua Ling, Wei-qing Chen, Yu-ming Chen · 2010 · Heart
  9. Cerebral Infarcts and Cognitive Performance
    Jane S. Saczynski, Sigurdur Oli Sigurdsson, Marıá K. Jónsdóttir, Guðný Eiríksdóttir, Pálmi V. Jónsson, Melissa E. Garcia, Ólafur Kjartansson, Oscar L. López, Mark A. van Buchem, Vilmundur G. Gudnason et al. · 2009 · Stroke
  10. The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases
    Vermeire, Séverine, Van Assche, Gert, Rutgeerts, Paul · 2005 · Nature Clinical Practice Gastroenterology & Hepatology
  11. High sensitivity C-reactive protein (hsCRP) & cardiovascular disease: An Indian perspective
    Prem S Pais, Deepak Y. Kamath, Denis Xavier, Alben Sigamani · 2015 · The Indian Journal of Medical Research
  12. Impact of Volatile Anesthetics on Oxidative Stress and Inflammation
    Yoon-Mi Lee, Byeng Chun Song, Kyung‐Jin Yeum · 2015 · BioMed Research International
  13. The Role of Immune System Parameters in the Relationship Between Depression and Coronary Artery Disease
    Willem J. Kop, John S. Gottdiener · 2005 · Psychosomatic Medicine
  14. Association of Platelet to Lymphocyte Ratio With Inflammation and Severity of Coronary Atherosclerosis in Patients With Stable Coronary Artery Disease
    Mehmet Kadri Akboğa, Uğur Canpolat, Çağrı Yayla, Fırat Özcan, Özcan Özeke, Serkan Topaloğlu, Dursun Aras · 2015 · Angiology
  15. Therapeutic potential of nitric oxide donors in the prevention and treatment of atherosclerosis
    Arnold G. Herman, Salvador Moncada · 2005 · European Heart Journal
  16. Cytokines and cardiovascular disease
    Vishal C. Mehra, Vinod S. Ramgolam, Jeffrey R. Bender · 2005 · Journal of Leukocyte Biology
  17. Antidepressant therapy and C-reactive protein levels
    Sinead M. O’Brien, Lucinda V. Scott, Timothy G. Dinan · 2006 · The British Journal of Psychiatry
  18. Genetic Variation Is Associated With C-Reactive Protein Levels in the Third National Health and Nutrition Examination Survey
    Dana C. Crawford, Christopher Sanders, Xiaoting Qin, Joshua D. Smith, Cynthia Shephard, Michelle Wong, Laura Witrak, Mark J. Rieder, Deborah A. Nickerson · 2006 · Circulation
  19. The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis
    Lina Panayiota Aristoteli, Holger Jon Møller, Brian Bailey, Søren K. Moestrup, Leonard Kritharides · 2005 · Atherosclerosis
  20. Depression and cardiovascular disease: Shared molecular mechanisms and clinical implications
    Mingjing Shao, Xiaodong Lin, Deguo Jiang, Hongjun Tian, Yong Ji Xu, Lina Wang, Feng Ji, Chunhua Zhou, Xueqing Song, Chuanjun Zhuo · 2020 · Psychiatry Research
  21. TMAO is Associated with Mortality: Impact of Modestly Impaired Renal Function
    Gruppen, Eke G., Garcia, Erwin, Connelly, Margery A., Jeyarajah, Elias J., Otvos, James D., Bakker, Stephan J. L., Dullaart, Robin P. F. · 2017 · Scientific Reports
  22. The JUPITER Trial
    Paul M. Ridker · 2009 · Circulation Cardiovascular Quality and Outcomes
  23. Association between ischemia-modified albumin, lipids and inflammation biomarkers in patients with hypercholesterolemia
    Marta Maria Medeiros Frescura Duarte, João Batista Teixeira da Rocha, Rafael Noal Moresco, Thiago Duarte, Ivana Beatrice Mânica da Cruz, Vânia Lúcia Loro, Maria Rosa Chitolina Schetinger · 2009 · Clinical Biochemistry
  24. Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery
    Christopher D. Owens, Paul M. Ridker, Michael Belkin, Allen D. Hamdan, Frank B. Pomposelli, Frank W. LoGerfo, Mark A. Creager, Michael S. Conte · 2006 · Journal of Vascular Surgery
  25. Elevated C-Reactive Protein Is a Predictor of the Development of Diabetes in a General Japanese Population
    Yasufumi Doi, Yutaka Kiyohara, Michiaki Kubo, Toshiharu Ninomiya, Yoshiyuki Wakugawa, Koji Yonemoto, Masanori Iwase, Mitsuo Iida · 2005 · Diabetes Care
  26. Keynote review: The adipocyte as a drug discovery target
    Andrea R. Nawrocki, Philipp E. Scherer · 2005 · Drug Discovery Today
  27. Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities?
    Sattar, N., Wannamethee, S. G., Forouhi, N. G. · 2008 · Diabetologia
  28. Simvastatin: a review
    Terje Rolf Pedersen, Jonathan A. Tobert · 2004 · Expert Opinion on Pharmacotherapy
  29. Red Cell Distribution Width and Risk of Coronary Heart Disease Events
    SANDIP K. ZALAWADIYA, Vikas Veeranna, Ashutosh Niraj, Jyotiranjan Pradhan, Luis Afonso · 2010 · The American Journal of Cardiology
  30. Weight loss leads to reductions in inflammatory biomarkers after a very-low-carbohydrate diet and a low-fat diet in overweight men
    Matthew J. Sharman, Jeff S. Volek · 2004 · Clinical Science
  31. Cognitive Impairment: An Increasingly Important Complication of Type 2 Diabetes: The Age, Gene/Environment Susceptibility-Reykjavik Study
    Saczynski, J. S., Jonsdottir, M. K., Garcia, M. E., Jonsson, P. V., Peila, R., Eiriksdottir, G., Olafsdottir, E., Harris, T. B., Gudnason, V., Launer, L. J. · 2008 · American Journal of Epidemiology
  32. ESR or CRP? A comparison of their clinical utility
    Andrew Osei-Bimpong, J. H. Meek, S. Mitchell Lewis · 2007 · Hematology
  33. Fibrinogen and coronary heart disease: test of causality by ‘Mendelian randomization’
    Bernard D. Keavney, John Danesh, Sarah Parish, Alison Palmer, Sarah Clark, Linda D. Youngman, Marc Délepine, Mark G. Lathrop, Richard Peto, Rory Collins · 2006 · International Journal of Epidemiology
  34. ICSH review of the measurement of the erythocyte sedimentation rate
    J. M. Jou, S. Mitchell Lewis, Carol Briggs, S.-H. LEE, Barbara De la Salle, Stefanie McFadden · 2011 · International Journal of Laboratory Hematology
  35. Pro-inflammatory cytokines in acute coronary syndromes: From bench to bedside
    Dimitris Tousoulis, Charalampos Antoniades, Nikolas Koumallos, Christodoulos Stefanadis · 2006 · Cytokine & Growth Factor Reviews
  36. Physical activity, obesity and cardiometabolic risk factors in 9- to 10-year-old UK children of white European, South Asian and black African-Caribbean origin: the Child Heart And health Study in England (CHASE)
    Christopher G. Owen, C. M. Nightingale, Alicja R. Rudnicka, Naveed A. Sattar, Derek G. Cook, Ulf Ekelund, Peter Hynes Whincup · 2010 · Diabetologia
  37. Inflammatory and non-invasive vascular markers: The multimarker approach for risk stratification in coronary artery disease
    Ignatios Ikonomidis, Kimon S. Stamatelopoulos, John P Lekakis, Georgia D. Vamvakou, Dimitrios Th. Kremastinos · 2008 · Atherosclerosis
  38. Cytokine Biomarkers, Endothelial Inflammation, and Atherosclerosis in the Metabolic Syndrome: Emerging Concepts
    Ali Abbas Rizvi · 2009 · The American Journal of the Medical Sciences
  39. DHA Supplementation Decreases Serum C-Reactive Protein and Other Markers of Inflammation in Hypertriglyceridemic Men
    Darshan Singh Kelley, David Siegel, Dawn M. Fedor, Yuriko C. Adkins, Bruce E. Mackey · 2009 · Journal of Nutrition
  40. Von Willebrand factor and ADAMTS13 in arterial thrombosis: a systematic review and meta-analysis
    Michelle Sonneveld, Moniek P.M. de Maat, Frank W.G. Leebeek · 2014 · Blood Reviews
  41. The double jeopardy of HDL
    Mohamad Navab, G. M. Ananthramaiah, Srinivasa T. Reddy, Brian J. Van Lenten, Benjamin J. Ansell, Susan Y. Hama, Greg Hough, Eugene Bachini, Victor R. Grijalva, Alan C. Wagner et al. · 2005 · Annals of Medicine
  42. Role of CD8 T Cell Replicative Senescence in Human Aging and in HIV-mediated Immunosenescence.
    Jeffrey Dock, Rita B. Effros · 2011 · Europe PMC (PubMed Central)
  43. C-reactive protein levels in early pregnancy, fetal growth patterns, and the risk for neonatal complications: the Generation R Study
    Gesina D.S. Ernst, Layla L. de Jonge, Albert Hofman D, Jan Willem Lindemans, Henk Russcher, Eric A.P. Steegers, Vincent W. V. Jaddoe · 2011 · American Journal of Obstetrics and Gynecology
  44. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: a prospective population study
    Mette Thomsen, Børge Grønne Nordestgaard, Jørgen Vestbo, Peter Lange · 2013 · The Lancet Respiratory Medicine
  45. DNA methylation signature of chronic low-grade inflammation and its role in cardio-respiratory diseases
    Matthias Wielscher, Pooja R. Mandaviya, Brigitte Kuehnel, Roby Joehanes, Rima Mustafa, Oliver Robinson, Yan Zhang, Barbara Bodinier, Esther Walton, Pashupati Prasad Mishra et al. · 2022 · Nature Communications
  46. Life course socioeconomic position is associated with inflammatory markers: The Framingham Offspring Study
    Eric B. Loucks, Louise Pilote, John William Lynch, Hugues Richard, N. Almeida, Emelia J. Benjamin, Joanne M. Murabito · 2010 · Social Science & Medicine
  47. Effect of sucrose on inflammatory markers in overweight humans
    Lone Brinkmann Sørensen, Anne Raben, Steen Stender, Arne Vernon Astrup · 2005 · American Journal of Clinical Nutrition
  48. Lutein exerts anti-inflammatory effects in patients with coronary artery disease
    Rosanna W. S. Chung, Per Leanderson, Anna K. Lundberg, Lena Jonasson · 2017 · Atherosclerosis
  49. Low ankle–brachial index predicts an adverse 1‐year outcome after acute coronary and cerebrovascular events
    Giancarlo Agnelli, Claudio Cimminiello, Giorgio Meneghetti, Stefano Urbinati · 2006 · Journal of Thrombosis and Haemostasis
  50. C-reactive protein as a biomarker for urological cancers
    Kazutaka Saito, Kazunori Kihara · 2011 · Nature Reviews Urology
  51. Early origins of inflammation: An examination of prenatal and childhood social adversity in a prospective cohort study
    Natalie B. Slopen, Eric B. Loucks, Allison A. Appleton, Ichiro I. Kawachi, Laura Diane Kubzansky, Amy L. Non, Stephen L. Buka, Stephen E. Gilman · 2014 · Psychoneuroendocrinology
  52. Cardiovascular risk parameters in men with ankylosing spondylitis in comparison with non-inflammatory control subjects: relevance of systemic inflammation
    Hiren Divecha, Naveed A. Sattar, Ann Rumley, Lynne Cherry, Gordon D O Lowe, Roger D. Sturrock · 2005 · Clinical Science
  53. Proinflammatory Effects of Bacterial Recombinant Human C-Reactive Protein Are Caused by Contamination With Bacterial Products, Not by C-Reactive Protein Itself
    Mark B. Pepys, Philip Nigel Hawkins, Melvyn Kahan, Glenys A. Tennent, J. Ruth Gallimore, David Graham, Caroline Anne Sabin, Arturo Zychlinsky, Juana de Diego · 2005 · Circulation Research
  54. Cardiovascular Disease and Risk Factors in Patients with Psoriasis and Psoriatic Arthritis
    Anne‐Marie Tobin, Douglas James Veale, Oliver FitzGerald, Sarah Rogers, Paul M. Collins, Donal Brendan O'Shea, Brian Kirby · 2010 · The Journal of Rheumatology
  55. High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus
    Nazanin Firooz, D A Albert, DJ Wallace, MARIKO L. ISHIMORI, Dror Berel, Michael H. Weisman · 2011 · Lupus
  56. Resting heart rate is associated with cardiovascular and all-cause mortality after adjusting for inflammatory markers: The Copenhagen City Heart Study
    Magnus Thorsten Jensen, Jacob Louis Marott, Kristine Højgaard Allin, Børge Grønne Nordestgaard, Gorm Boje Jensen · 2011 · European Journal of Preventive Cardiology
  57. Systemic inflammation and resting state connectivity of the default mode network
    Anna L. Marsland, Dora C.-H. Kuan, Lei K. Sheu, Katarina Krajina, Thomas E. Kraynak, Stephen B. Manuck, Peter J. Gianaros · 2017 · Brain Behavior and Immunity
  58. Association of serum total bilirubin level with severity of coronary atherosclerosis is linked to systemic inflammation
    Mehmet Kadri Akboğa, Uğur Canpolat, Asife Şahinarslan, Yakup Alsancak, Serdar Gökhan Nurkoç, Dursun Aras, Sinan Aydoğdu, Adnan Abacı · 2015 · Atherosclerosis
  59. C-Reactive Protein Is Associated With Obstructive Sleep Apnea Independent of Visceral Obesity
    Macy Mei‐Sze Lui, Jamie C.M. Lam, Henry Ka‐Fung Mak, Aimin Xu, Clara G. C. Ooi, David Chi-Leung Lam, Jcw Mak, Pek Lan Khong, Msm Ip · 2009 · CHEST Journal
  60. The relative influences of fitness and fatness on inflammatory factors
    Mark Hamer · 2006 · Preventive Medicine
  61. Complement and non-complement activating functions of C1q: A prototypical innate immune molecule
    Annapurna Nayak, Lina Pednekar, Kenneth B. M. Reid, Uday Kishore · 2011 · Innate Immunity
  62. CRP and the risk of atherosclerotic events
    Paolo Calabrò, Enrica Golia, Edward T.H. Yeh · 2009 · Seminars in Immunopathology
  63. Renal Function and Risk of Coronary Heart Disease in General Populations: New Prospective Study and Systematic Review
    Emanuele Di Angelantonio, John Danesh, Guðný Eiríksdóttir, Vilmundur G. Gudnason · 2007 · PLoS Medicine
  64. Association Between Inflammation and Insulin Resistance in U.S. Nondiabetic Adults
    Jing Chen, Rachel P. Wildman, L. Lee Hamm, Paul Muntner, Kristi Reynolds, Paul Kieran Whelton, Jiang He · 2004 · Diabetes Care
  65. Association of Multiple Inflammatory Markers with Carotid Intimal Medial Thickness and Stenosis (from the Framingham Heart Study)
    Avni H. Thakore, Chao‐Yu Guo, Martin G. Larson, Diane Corey, Thomas J. Wang, Ramachandran Srini Vasan, Ralph B. D’Agostino, Izabella Lipinska, John F. Keaney, Emelia J. Benjamin et al. · 2007 · The American Journal of Cardiology
  66. Chronic Exposure to Outdoor Air Pollution and Markers of Systemic Inflammation
    Lindsay J L Forbes, Minal D. Patel, Alicja R. Rudnicka, Derek G. Cook, Tony Bush, John R. Stedman, Peter Hynes Whincup, David Peter Strachan, Ross Anderson · 2009 · Epidemiology
  67. Inflammation and atherosclerosis in rheumatoid arthritis
    Robert J. Stevens, Karen Douglas, Athanasios N. Saratzis, George D. Kitas · 2005 · Expert Reviews in Molecular Medicine
  68. Selected dietary flavonoids are associated with markers of inflammation and endothelial dysfunction in U.S. women
    Landberg, Rikard, Sun, Qi, Rimm, Eric B., Cassidy, Aedin, Scalbert, Augustin, Mantzoros, Christos S., Hu, Frank B., van Dam, Rob M. · 2011 · The Journal of Nutrition
  69. Inflammation and myeloproliferative neoplasms
    Lussana, Federico, Rambaldi, Alessandro · 2017 · Journal of Autoimmunity
  70. Prognostic value of coronary artery calcium screening in asymptomatic smokers and non-smokers
    Leslee J. Shaw, Paolo Raggi, Tracy Q. Callister, Daniel S. Berman · 2006 · European Heart Journal
  71. PCSK9 inhibition and inflammation: A narrative review
    Massimiliano Ruscica, Lale S Tokgözoğlu, Alberto Corsini, Cesare Riccardo Sirtori · 2019 · Atherosclerosis
  72. Loss of Pentameric Symmetry in C-Reactive Protein Induces Interleukin-8 Secretion Through Peroxynitrite Signaling in Human Neutrophils
    Tarek Khreiss, Levente József, Lawrence A. Potempa, János G. Filep · 2005 · Circulation Research
  73. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus
    Joan Marie Von Feldt, Lisabeth V. Scalzi, Andrew J. Cucchiara, Suneetha Morthala, Carmel Kealey, Stephanie D. Flagg, Anna Genin, Alison L. Van Dyke, Eleni Nackos, A. Chander et al. · 2006 · Arthritis & Rheumatism
  74. N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population
    Michael Hecht Olsen, Tine W. Hansen, Marina K. Christensen, Finn Gustafsson, S. Rasmussen, Kristian Wachtell, Hans Ibsen, Christian Tobias Torp-Pedersen, Per Rossen Hildebrandt · 2007 · European Heart Journal
  75. Diet-Induced Weight Loss Is Associated with Decreases in Plasma Serum Amyloid A and C-Reactive Protein Independent of Dietary Macronutrient Composition in Obese Subjects
    Kevin D. O’Brien, Bonnie J. Brehm, Randy J. Seeley, Judy A. Bean, Mark H. Wener, Stephen R. Daniels, David A. D’Alessio · 2005 · The Journal of Clinical Endocrinology & Metabolism
  76. Monitoring of inflammation in patients on dialysis: forewarned is forearmed
    Christiaan Lucas Meuwese, Peter Stenvinkel, Friedo Wilhelm Dekker, Juan Jesús Carrero · 2011 · Nature Reviews Nephrology
  77. Loneliness and the metabolic syndrome in a population-based sample of middle-aged and older adults.
    Mark A. Whisman · 2010 · Health Psychology
  78. Circulating Biomarkers for Predicting Cardiovascular Disease Risk; a Systematic Review and Comprehensive Overview of Meta-Analyses
    Thijs C. van Holten, Leonie F. Waanders, Philip G. de Groot, Joost L. M. Vissers, Imo E. Hoefer, Gerard Pasterkamp, Menno W. J. Prins, Mark Roest · 2013 · PLoS ONE
  79. 2004 MacLean-Mueller prize enteral or parenteral nutrition for severe pancreatitis: a randomized controlled trial and health technology assessment.
    Brian E. Louie, Tom Noseworthy, David M. Hailey, Leah M Gramlich, Philip Jacobs, Garth L. Warnock · 2005 · PubMed Central
  80. Associations of Inflammatory and Hemostatic Variables With the Risk of Recurrent Stroke
    Mark Woodward, Gordon D O Lowe, Duncan John Campbell, Sam Colman, Ann Rumley, John Philip Chalmers, Bruce Charles Neal, Anushka A Patel, Alicia Josephine Jenkins, Bruce E. Kemp et al. · 2005 · Stroke
  81. Associations between nut consumption and inflammatory biomarkers,
    Zhi Yu, Vasanti Malik, NaNa Keum, Frank B. Hu, Edward L. Giovannucci, Meir J. Stampfer, Walter Churchill Willett, Charles S. Fuchs, Ying Bao · 2016 · American Journal of Clinical Nutrition
  82. The year in atherothrombosis
    Pedro Moreno, Valentı́n Fuster · 2004 · Journal of the American College of Cardiology
  83. C-Reactive Protein and Prediction of Coronary Heart Disease and Global Vascular Events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)
    Naveed A. Sattar, Heather M. Murray, Alex McConnachie, Gerard J. Blauw, Edward L.E.M. Bollen, Brendan Martin Buckley, Stuart M. Cobbe, Ian Ford, Allan Gaw, Michael Hyland et al. · 2007 · Circulation
  84. Activation of Peripheral Blood CD14+ Monocytes Occurs in Diabetes
    Christine Cipolletta, Kathryn Ryan, Elinor Hanna, Elisabeth R. Trimble · 2005 · Diabetes
  85. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
    Mach, François, Baigent, Colin, Catapano, Alberico L, Koskinas, Konstantinos C, Casula, Manuela, Badimon, Lina, Chapman, M John, De Backer, Guy G, Delgado, Victoria, Ference, Brian A et al. · 2020 · European Heart Journal
  86. Primary Prevention of ASCVD and T2DM in Patients at Metabolic Risk: An Endocrine Society* Clinical Practice Guideline
    James L. Rosenzweig, George L. Bakris, Lars Berglund, Marie‐France Hivert, Edward S. Horton, Rita Rastogi Kalyani, Mohammad Hassan Murad, Bruno L Vergès · 2019 · The Journal of Clinical Endocrinology & Metabolism
  87. The usage of a simplified self‐titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes – results of the randomized, controlled PREDICTIVE™ 303 study
    Luigi Meneghini, Christoph Koenen, Wayne Weng, J. L. Selam · 2007 · Diabetes Obesity and Metabolism
  88. Prevalence and treatment of atherogenic dyslipidemia in the primary prevention of cardiovascular disease in Europe: EURIKA, a cross-sectional observational study
    Halcox, Julian P., Banegas, José R., Roy, Carine, Dallongeville, Jean, De Backer, Guy, Guallar, Eliseo, Perk, Joep, Hajage, David, Henriksson, Karin M., Borghi, Claudio · 2017 · BMC Cardiovascular Disorders
  89. Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: A prospective birth cohort study
    Stephen A. Metcalf, Peter Brian Jones, Tanja Nordström, Markku Timonen, Pirjo H. Mäki, Jouko Miettunen, Erika Jääskeläinen, Marjo‐Riitta Järvelin, Jan Štochl, Graham K. Murray et al. · 2016 · Brain Behavior and Immunity
  90. Vascular comorbidity in rheumatoid arthritis: potential mechanisms and solutions
    Naveed A. Sattar, Iain B. McInnes · 2005 · Current Opinion in Rheumatology
  91. High sensitive and selective C-reactive protein detection by means of lossy mode resonance based optical fiber devices
    Pablo Zubiate, Carlos R. Zamarreño, Pedro Sánchez, Ignacio Raul Matias, Francisco Javier Arregui · 2016 · Biosensors and Bioelectronics
  92. Interleukin-6, Fibrin D-Dimer, and Coagulation Factors VII and XIIa in Prediction of Coronary Heart Disease
    Gordon D O Lowe, Ann Rumley, Alex D. McMahon, Ian Ford, Denis St J O’Reilly, Christopher J. Packard · 2004 · Arteriosclerosis Thrombosis and Vascular Biology
  93. Inflammation in Coronary Artery Disease
    Georgios Christodoulidis, Timothy J. Vittorio, Marat Fudim, Stamatios Lerakis, Constantine E. Kosmas · 2014 · Cardiology in Review
  94. Interleukin 18 and coronary heart disease: Prospective study and systematic review
    Barbara J.M.H. Jefferis, Olia Papacosta, Christopher G. Owen, S. Goya Wannamethee, Steve Eric Humphries, Mark Woodward, LUCY T. LENNON, Andrew G. Thomson, Paul I. Welsh, Ann Rumley et al. · 2011 · Atherosclerosis
  95. Short Communication: From Wasting to Obesity: Initial Antiretroviral Therapy and Weight Gain in HIV-Infected Persons
    Wanda C. Lakey, Lan‐Yan Yang, William S. Yancy, Shein‐Chung Chow, Charles B. Hicks · 2012 · AIDS Research and Human Retroviruses
  96. Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men
    Tobias Pischon, Frank B. Hu, Kathryn M. Rexrode, Cynthia J. Girman, JoAnn E. Manson, Eric B. Rimm · 2007 · Atherosclerosis
  97. Whole and Refined Grain Intakes Are Related to Inflammatory Protein Concentrations in Human Plasma
    Masters, Rachel C., Liese, Angela D., Haffner, Steven M., Wagenknecht, Lynne E., Hanley, Anthony J. · 2010 · The Journal of Nutrition
  98. Cumulative Exposure to High‐Sensitivity C‐Reactive Protein Predicts the Risk of Cardiovascular Disease
    Aitian Wang, Jie Liu, Chunguang Li, Jingli Gao, Xiaolan Li, Shuohua Chen, Shouling Wu, Hui Ding, Haojun Fan, Shike Hou · 2017 · Journal of the American Heart Association
  99. Multiplexed flow cytometric analyses of pro‐ and anti‐inflammatory cytokines in the culture media of oxysterol‐treated human monocytic cells and in the sera of atherosclerotic patients
    Céline Prunet, Thomas Montange, Anne Véjux, Aline Laubriet, Jean‐François Rohmer, Jean‐Marc Riedinger, Anne Athias, Stéphanie Lemaire‐Ewing, Dominique Néel, Jean‐Michel Petit et al. · 2006 · Cytometry Part A
  100. Chronic obstructive pulmonary disease and sudden cardiac death: the Rotterdam study
    Lies Lahousse, Maartje N. Niemeijer, Marten E. van den Berg, Peter R. Rijnbeek, Guy Joos, Albert Hofman D, Oscar H. Franco, Jaap Willem Deckers, Mark Eijgelsheim, Bruno H. Ch. Stricker et al. · 2015 · European Heart Journal